IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ishara Investments LP

Portfolio Profile

CIK: 0002111609 | LOS ANGELES, CA

Investment Profile

Style

GARP

Turnover

Very High

Orientation

Concentrated trader
$136.1M
AUM
41
Positions
50.98%
Top 10 Conc.
87.15%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Acadia Pharmaceuticals Inc(ACAD)410,000$10.4M7.62%
2Xeris Biopharma Holdings Inc(XERS)1,230,000$9.7M7.16%
3Biomarin Pharmaceutical Inc(BMRN)143,500$8.2M6.03%
4Praxis Precision Medicines I(PRAX)22,550$7.5M5.55%
5Ultragenyx Pharmaceutical in(RARE)205,000$6.8M5.03%

Sector Allocation

Latest filing, equity positions only

Healthcare97.45% · $132.6M
Unclassified2.55% · $3.5M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare97.28%97.45%+0.17%
Unclassified2.72%2.55%-0.17%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$87.5M | 38 pos.
$105.6M | 37 pos.
$136.1M | 41 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

16
New
12
6
Agios Pharmaceuticals Inc(AGIO)
164,000
$6.1M
4.47%
7Insmed Inc(INSM)51,250$5.5M4.01%
8Crinetics Pharmaceuticals in(CRNX)143,500$5.4M3.95%
9Zentalis Pharmaceuticals Inc(ZNTL)1,025,000$5.0M3.65%
10Vaxcyte Inc(PCVX)82,000$4.8M3.50%
Cap SizePrev %Curr %Change
Small Cap38.44%39.5%+1.06%
Mid Cap47.05%33.56%-13.49%
Large Cap8.61%17.29%+8.68%
Micro Cap3.18%7.1%+3.92%
Unclassified2.72%2.55%-0.17%
Closed
13
Increased
8
Decreased
4
Unchanged